Subclinical organ damage Treatment LVH

Slides:



Advertisements
Similar presentations
The role of lercanidipine in the treatment of hypertension:
Advertisements

Preventing Strokes One at a Time Acute Interventions and Management 2009.
The Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Internal Medicine/Pediatrics.
Hypertension – Summary
Canadian Diabetes Association Clinical Practice Guidelines Treatment of Diabetes in People with Heart Failure Chapter 28 Jonathan G. Howlett, John C. MacFadyen.
Hypertension - general overview (guidelines ) Hypertension - general overview (guidelines ) Andrzej Tomaszewski Ass. Prof. M.D. Ph. D. Dept. of Cardiology,
Drugs for Hypertension
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial ALLHAT study overview Double-blind, randomized trial to determine whether.
Recent Guidelines for the Management of Arterial Hypertension (Part II) Christos G. Savopoulos Assistant Professor of Internal Medicine 1 st Propedeutic.
Success and Predictors of Blood Pressure Control in Diverse North American Settings: The Antihypertensive and Lipid- lowering Treatment to Prevent Heart.
 Hypertension : BPDIASTOLIC SYSTOLIC Normal< 130< 85 Mild hypertension Moderate hypertension Severe Hypertension 180.
Hypertension In elderly population. JNC VII BP Classification SBP mmHgDBP mmHg Normal
Systolic hypertension not an isolated problem Michael Weber, MD Professor of Medicine Associate Dean Downstate College of Medicine State University of.
Definitions and classification of office blood pressure levels (mmHg) Modified by ESC Guidelines 2013 CARDIOcheckAPP.
Avoiding Cardiovascular Events through COMbination Therapy in Patients LIving with Systolic Hypertension The First Outcomes Trial of Initial Therapy With.
1 Current & New treatment strategies to address CV Risk.
UPDATE ON MANAGEMENT OF HYPERTENSION. Classification of BLOOD PRESSURE for adults 18 yrs. Or older BP ClassificationSystolic BP, mm of hgDiastolic BP,
Antihypertensives Dr Thabo Makgabo.
Radka Adlová Arterial hypertension and preventive cardiology.
ALLHAT Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial JAMA 2002;288:
Hypertension Family Medicine Specialist CME October 15-17, 2012 Pakse.
Antihypertensive Drugs
Dr.AZDAKI (cardiologist).   Initial monotherapy is successful in many patients with mild primary hypertension (formerly called "essential" hypertension).
Internal Medicine Workshop Series Laos September /October 2009.
Date of download: 6/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Quality of Care of and Outcomes for African Americans.
Evidence based medicine Antihypertensive drugs in the elderly Group 1 and 6 -Heba Othman -Heba Sabry -Reem Ahmed -Dina Reda -Dalia El Magraby.
Hypertension In The Stroke Patient
Fig ACCF/AHA Guideline for the management of heart failure
JNC VIII Hypertension.
Hypertension JNC VIII Guidelines.
Baseline characteristics and effectiveness results
Nursing Care of Patients with Hypertension
Copyright © 2005 American Medical Association. All rights reserved.
Drugs for Hypertension
Hypertension Pharmcology.
The Anglo Scandinavian Cardiac Outcomes Trial
2013 ESH-ESC Guidelines for the Management of Arterial Hypertension
Проценка на кардиоваскуларен ризик и препораки за третман
Management of High Blood Pressure in Blacks
Hypertension: A Risk Factor For Stroke
UNIT 2: ANTIHYPERTENSIVE DRUGS
Jeannine Costigan RN(EC) Nurse Practitioner Heart Function Clinic
Mean BP from initial visit to four years
Emerging Mechanisms in Glucose Metabolism
Nat. Rev. Nephrol. doi: /nrneph
Prevalence of statin and beta-blocker use by clinical presentation
Drug Rate ratio 95% CI Thiazide diuretics 1.0 Reference ACE inhibitors
Step Care Therapy for Hypertension in Diabetic Patients
UNIT 2: ANTIHYPERTENSIVE DRUGS
Relative risks for heart failure: Framingham Study
Jeannine Costigan RN(EC) Nurse Practitioner Heart Function Clinic
Jeannine Costigan RN(EC) Nurse Practitioner Heart Function Clinic
Category Hypertension Normal < 130/< 85 Recheck in 2 years. High Normal 130–139/ 85–89 Recheck in 1 year Hypertension Stage 1 (mild) 140–159/90–99.
Department of General Practice QUB
Avoiding Cardiovascular Events through COMbination Therapy in Patients LIving with Systolic Hypertension The First Outcomes Trial of Initial Therapy With.
Table of Contents Why Do We Treat Hypertension? Recommendation 5
The Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) Study was a double-blind, randomized, placebo-controlled study.
Primary Hypertension Max C. Reif, M.D.
Anti hypertensive Drugs
Hypertension is defined as systolic blood pressure (SBP) of 140 mmHg or greater, diastolic blood pressure (DBP) of 90 mmHg or greater, or taking antihypertensive.
The following slides highlight a report by Dr
Managing Blood Pressure
Pharmacological Treatment of Hypertension Update 2012
Internal Medicine Workshop Series Laos September /October 2009
Adjusted ORs of AF within 30 days after bereavement with specific characteristics versus non-bereaved with the same characteristics. * *The vertical dashed.
KDOQI US Commentary on the 2017 ACC/AHA Hypertension Guideline
Adjusted ORs of AF according to time since bereavement versus non-bereaved in a population from Denmark between 1995 and * *ORs are adjusted for.
Recommendations for the treatment of confirmed hypertension in people with diabetes. *An ACE inhibitor (ACEi) or angiotensin receptor blocker (ARB) is.
An updated general approach for achieving BP goals in people with diabetes. An updated general approach for achieving BP goals in people with diabetes.
β-Blocker Use for the Stages of Heart Failure
Presentation transcript:

Antihypertensive treatment: Preferred drugs as per new European guidelines Subclinical organ damage Treatment LVH ACE inhibitors, calcium antagonists, angiotensin receptor blockers Asymptomatic atherosclerosis Calcium antagonists, ACE inhibitors Microalbuminuria ACE inhibitors, angiotensin receptor blockers Renal dysfunction LVH=left ventricular hypertrophy ESRD=end-stage renal disease PAD=peripheral arterial disease ISH=isolated systolic hypertension Mancia G et al. J Hypertens 2007; 25:1105-1187.

Antihypertensive treatment: Preferred drugs as per new European guidelines Clinical event Treatment Previous stroke Any BP-lowering agent Previous MI Beta blockers, ACE inhibitors, angiotensin receptor blockers Angina pectoris Beta blockers, calcium antagonists Heart failure Diuretics, beta blocker, ACE inhibitors, angiotensin receptor blockers, antialdosterone agents LVH=left ventricular hypertrophy ESRD=end-stage renal disease PAD=peripheral arterial disease ISH=isolated systolic hypertension Mancia G et al. J Hypertens 2007; 25:1105-1187.

Antihypertensive treatment: Preferred drugs as per new European guidelines Clinical event Treatment Atrial fibrillation   Recurrent Angiotensin receptor blockers, ACE inhibitors Permanent Beta blockers, nonhydropyridine calcium antagonists ESRD/proteinuria ACE inhibitors, angiotensin receptor blockers, loop diuretics PAD Calcium antagonists LVH=left ventricular hypertrophy ESRD=end-stage renal disease PAD=peripheral arterial disease ISH=isolated systolic hypertension Mancia G et al. J Hypertens 2007; 25:1105-1187.

Antihypertensive treatment: Preferred drugs as per new European guidelines Condition  Treatment ISH (elderly) Diuretics, calcium antagonists Metabolic syndrome ACE inhibitors, angiotensin receptor blockers, calcium antagonists Diabetes mellitus ACE inhibitors, angiotensin receptor blockers Pregnancy Calcium antagonists, methyldopa, beta blockers Blacks LVH=left ventricular hypertrophy ESRD=end-stage renal disease PAD=peripheral arterial disease ISH=isolated systolic hypertension Mancia G et al. J Hypertens 2007; 25:1105-1187.